{"id":"caivt-10-5","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Runny nose"},{"rate":"5-15%","effect":"Cough"},{"rate":"5-10%","effect":"Fever"}]},"_chembl":{"chemblId":"CHEMBL39541","moleculeType":"Small molecule","molecularWeight":"785.11"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"It works by inducing an immune response against the virus, providing protection against infection.","oneSentence":"CAIVT 10^5 is a live attenuated virus vaccine.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T02:30:40.389Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Respiratory syncytial virus infection"}]},"trialDetails":[{"nctId":"NCT00192322","phase":"PHASE2","title":"Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine (CAIV-T) in Healthy Children","status":"COMPLETED","sponsor":"MedImmune LLC","startDate":"2001-09","conditions":"Influenza","enrollment":173}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"CAIVT 10^5","genericName":"CAIVT 10^5","companyName":"MedImmune LLC","companyId":"medimmune-llc","modality":"Biologic","firstApprovalDate":"","aiSummary":"CAIVT 10^5 is a live attenuated virus vaccine. Used for Respiratory syncytial virus infection.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}